Between 2022 and 2035, the bioavailability enhancement services market will see an 11 percent compound annual growth rate, a report has predicted.
List view / Grid view
HIV patients received real-time antiretroviral dosage data from an innovative edible sensor in a clinical trial.
Co-injecting doxorubicin with LATTE, a novel ionic liquid formulation, resulted in uniform chemotherapy delivery and successful ablation in solid tumours.
Peginterferon-lambda rapidly reduced non-hospitalised COVID-19 patients’ viral loads and expedited their recovery in a Phase II study.
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded TB Alliance a CETR grant for tuberculosis drug development.
Device can deliver drugs, proteins and stem cells directly to diseased tissue...
An Emulate, Inc. study has demonstrated that its Blood Vessel-Chip accurately modelled and predicted thrombosis, or clotting of blood, induced by certain monoclonal antibody drugs, specifically anti-CD154 monoclonal antibody (mAb) hu5c8.
Broadly neutralising antibody treatment may target viral reservoir in monkeys...
In a bid to maximise the effectiveness of treatment for patients, doctors have been using predictive models. New research finds that accessing data from electronic medical records could greatly benefit this practice.
New tests to detect early Lyme disease - which is increasing beyond the summer months - could replace existing tests that often do not clearly identify the infection before health problems occur.
10 October 2014 | By The Harvard Stem Cell Institute
Giant step toward new diabetes treatment...
21 April 2011 | By Harvard School of Public Health (HSPH)
Researchers have identified several genes that may be implicated in the malaria parasite's ability to rapidly evade drug treatments...
28 February 2011 | By UCB
UCB announced today that it has concluded an innovative research collaboration agreement with Harvard University...